Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 4, 2010
Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer
D Craig Allred
Breast Cancer Research : BCR
|
January 9, 2009
The utility of conventional and molecular pathology in managing breast cancer
D Craig Allred
Cancer Prevention Research (Philadelphia, Pa.)
|
December 7, 2011
Molecular biomarkers of risk in premalignancy and breast cancer prevention
D Craig Allred
Journal of the National Cancer Institute. Monographs
|
October 20, 2010
Ductal carcinoma in situ: terminology, classification, and natural history
D Craig Allred
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2008
Problems and solutions in the evaluation of hormone receptors in breast cancer
D Craig Allred
The Oncologist
|
November 7, 2008
Commentary: hormone receptor testing in breast cancer: a distress signal from Canada
D Craig Allred
Journal of the National Cancer Institute
|
April 30, 2010
Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone
D Craig Allred
Breast Cancer Research and Treatment
|
September 4, 2010
High-resolution analyses of gene copy number reveal new insights into the prognosis and progression of breast cancers
Alejandro Gru, D Craig Allred
Journal of Mammary Gland Biology and Neoplasia
|
August 16, 2008
The relevance of mouse models to understanding the development and progression of human breast cancer
D Craig Allred, Daniel Medina
American Journal of Clinical Pathology
|
October 4, 2005
ER expression is not bimodal in breast cancer
D Craig Allred, Syed K Mohsin
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 4, 2010
Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer
D Craig Allred
Breast Cancer Research : BCR
|
January 9, 2009
The utility of conventional and molecular pathology in managing breast cancer
D Craig Allred
Cancer Prevention Research (Philadelphia, Pa.)
|
December 7, 2011
Molecular biomarkers of risk in premalignancy and breast cancer prevention
D Craig Allred
Journal of the National Cancer Institute. Monographs
|
October 20, 2010
Ductal carcinoma in situ: terminology, classification, and natural history
D Craig Allred
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2008
Problems and solutions in the evaluation of hormone receptors in breast cancer
D Craig Allred
The Oncologist
|
November 7, 2008
Commentary: hormone receptor testing in breast cancer: a distress signal from Canada
D Craig Allred
Journal of the National Cancer Institute
|
April 30, 2010
Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone
D Craig Allred
Breast Cancer Research and Treatment
|
September 4, 2010
High-resolution analyses of gene copy number reveal new insights into the prognosis and progression of breast cancers
Alejandro Gru, D Craig Allred
Journal of Mammary Gland Biology and Neoplasia
|
August 16, 2008
The relevance of mouse models to understanding the development and progression of human breast cancer
D Craig Allred, Daniel Medina
American Journal of Clinical Pathology
|
October 4, 2005
ER expression is not bimodal in breast cancer
D Craig Allred, Syed K Mohsin
Page
of 10